Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparinized saline flushing vs prophylactic enoxaparin to prevent central venous catheter thrombosis
IRCT20230428058015N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in Phlebothrombosis and catheter-related thrombosis (CRT) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Incidence of central venous catheter thrombosis. Started Mar 2021; status: completed.
02
Drugs
enoxaparin
03
Conditions
Phlebothrombosiscatheter-related thrombosis (CRT)
Beyond the preview
Go deeper on IRCT20230428058015N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230428058015N1.